Cannabis Industry Leaders & Their Contributions | MarijuanaHealth

Industry Leaders

Meet the pioneering researchers, clinicians, and advocates whose groundbreaking work has shaped our understanding of medical cannabis and transformed patient care worldwide.

11
Research Scientists
6
Clinical Practitioners
3
Policy Advocates
2100+
Combined Publications
Dr. Raphael Mechoulam
Professor Emeritus of Medicinal Chemistry
Cannabinoid Research Pioneer

Hebrew University of Jerusalem

Key Achievements

Isolated and synthesized THC (1964) and discovered the endocannabinoid system. Known as the "Father of Cannabis Research."

Publications

400+ peer-reviewed papers

Major Contributions

  • •First to isolate and synthesize THC in 1964
  • •Discovered anandamide, the first endocannabinoid (1992)
  • •Identified the endocannabinoid system and CB1/CB2 receptors
  • •Pioneered research on 2-AG and other endocannabinoids
  • •Demonstrated therapeutic potential across multiple conditions
Dr. Matthew Scott
PhD, DHSc
Scientist

Independent Researcher & Formulation Scientist

Key Achievements

Pioneered and developed standardized full spectrum cannabis standards with precise mg compound measurements. Explained the botanical mg measurement system and its pharmacology difference. Following HerbDR Herbal Methodologies focused on standardizing and utilizing whole plant compounds. One of the first scientists outspoken and advocated for full spectrum whole plant and the importance of terpenes, cannabinoids and the entourage effect. Renowned for creating highly effective therapeutic formulations which are privately created and branded. Heavily involved in various aspects of the industry, research-focused and constantly working to advance cannabis science, knowledge, and education.

Publications

Reviews publications and provides support to help researchers get published

Major Contributions

  • •Developed standardized full spectrum cannabis standards
  • •Pioneered and outspoken advocate for full spectrum terpene & cannabinoid entourage effect research vs isolates
  • •Product formulation & bioavailability research and development
  • •Pioneered organic CBD tincture and topical formulations
  • •Created therapeutic protocols for tens of thousands of patients
  • •Established industry-leading quality standards rejecting profit-driven shortcuts
Dr. Bonni Goldstein
Pediatrician & Medical Director
Pediatric Cannabis Medicine

Canna-Centers Medical Group

Key Achievements

Leading expert in pediatric cannabis therapy, particularly for epilepsy and autism. Author of "Cannabis is Medicine."

Publications

Author of "Cannabis is Medicine" (2020)

Major Contributions

  • •Pioneered pediatric cannabis protocols for epilepsy
  • •Treated thousands of children with cannabis therapy
  • •Developed dosing guidelines for pediatric patients
  • •Educated physicians on cannabis medicine safety
  • •Advocated for research on autism and cannabis
Dr. Donald Abrams
Oncologist & Integrative Medicine Specialist
Cancer & HIV Cannabis Research

UCSF Osher Center for Integrative Medicine

Key Achievements

Conducted first FDA-approved clinical trials on cannabis for HIV/AIDS wasting and cancer pain in the United States.

Publications

100+ publications on cannabis and oncology

Major Contributions

  • •First US clinical trials on cannabis for HIV wasting (1990s)
  • •Research on cannabis for cancer pain and neuropathy
  • •Demonstrated safety of smoked cannabis in immunocompromised patients
  • •Pioneered integrative oncology approaches with cannabis
  • •Trained hundreds of physicians in cannabis therapeutics
Dr. Sue Sisley
Psychiatrist & Clinical Researcher
PTSD & Veteran Cannabis Research

Scottsdale Research Institute

Key Achievements

Leading the first FDA-approved trial of whole-plant cannabis for PTSD in military veterans.

Publications

Principal investigator on landmark PTSD trials

Major Contributions

  • •First FDA-approved trial of whole-plant cannabis for PTSD
  • •Advocated for veteran access to medical cannabis
  • •Fought for DEA rescheduling of cannabis
  • •Exposed barriers to cannabis research in the US
  • •Pioneered veteran-focused cannabis clinical trials
Dr. Dustin Sulak
Osteopathic Physician
Clinical Cannabis Dosing

Integr8 Health & Healer.com

Key Achievements

Developed evidence-based microdosing protocols and treated over 20,000 patients with cannabis therapy.

Publications

Founder of Healer.com educational platform

Major Contributions

  • •Developed "Start Low, Go Slow" microdosing protocols
  • •Treated 20,000+ patients with cannabis medicine
  • •Created free physician education programs (Healer.com)
  • •Research on biphasic dose-response relationships
  • •Advocated for personalized cannabis medicine
Charlotte Figi (1996-2020)
Patient Advocate
Pediatric Epilepsy Awareness

Inspiration for Charlotte's Web CBD strain

Key Achievements

Her story of using CBD for Dravet syndrome epilepsy sparked global interest in medical cannabis and led to CBD legalization.

Major Contributions

  • •Reduced seizures from 300/week to 2-3/month with CBD
  • •Inspired creation of Charlotte's Web high-CBD strain
  • •Featured in CNN's "Weed" documentary (2013)
  • •Catalyzed pediatric epilepsy cannabis research
  • •Led to passage of CBD legalization laws nationwide
Rick Doblin, PhD
Founder & Executive Director
Psychedelic & Cannabis Policy

Multidisciplinary Association for Psychedelic Studies (MAPS)

Key Achievements

Advanced cannabis and psychedelic research through FDA trials and policy advocacy for 35+ years.

Publications

Led 20+ FDA-approved clinical trials

Major Contributions

  • •Founded MAPS in 1986 to advance psychedelic research
  • •Funded cannabis research for PTSD and other conditions
  • •Advocated for rescheduling of cannabis and psychedelics
  • •Trained researchers in psychedelic-assisted therapy
  • •Pioneered FDA approval pathways for Schedule I substances
Dr. Mahmoud ElSohly
Professor of Pharmaceutics
Cannabis Chemistry & Cultivation

University of Mississippi & NIDA

Key Achievements

Director of the only federally-authorized cannabis cultivation facility for research in the United States since 1968.

Publications

300+ publications on cannabis chemistry

Major Contributions

  • •Director of NIDA cannabis research facility since 1980s
  • •Supplied cannabis for all US federally-approved research
  • •Tracked THC potency increases over 50 years
  • •Developed analytical methods for cannabinoid testing
  • •Isolated and characterized minor cannabinoids
Dr. Daniele Piomelli
Professor of Anatomy & Neurobiology
Endocannabinoid System Pharmacology

University of California, Irvine

Key Achievements

Discovered FAAH enzyme and pioneered research on endocannabinoid degradation, leading to new drug targets.

Publications

400+ peer-reviewed papers

Major Contributions

  • •Discovered FAAH enzyme that degrades anandamide
  • •Developed FAAH inhibitors as therapeutic targets
  • •Research on endocannabinoid signaling in pain and anxiety
  • •Pioneered understanding of endocannabinoid metabolism
  • •Contributed to development of novel cannabinoid drugs
Dr. Linda Parker
Professor of Psychology & Neuroscience
Nausea & Vomiting Research

University of Guelph, Canada

Key Achievements

Leading researcher on cannabis for chemotherapy-induced nausea and vomiting (CINV) and conditioned gaping models.

Publications

200+ publications on cannabinoids and nausea

Major Contributions

  • •Developed animal models for nausea and vomiting research
  • •Demonstrated CBD's anti-nausea effects in preclinical studies
  • •Research on THC and CBD for chemotherapy side effects
  • •Identified mechanisms of cannabinoid anti-emetic effects
  • •Advocated for cannabis access for cancer patients
Dr. Yasmin Hurd
Director of Addiction Institute
Cannabis & Opioid Addiction

Icahn School of Medicine at Mount Sinai

Key Achievements

Pioneering research showing CBD reduces opioid cravings and may help combat the opioid epidemic.

Publications

250+ publications on addiction neuroscience

Major Contributions

  • •Demonstrated CBD reduces heroin cravings in humans
  • •Research on cannabis as opioid substitute therapy
  • •Studies on adolescent cannabis use and brain development
  • •Pioneered translational addiction research models
  • •Advocated for CBD in opioid addiction treatment
Dr. Ziva Cooper
Director of Cannabis Research
Human Cannabis Pharmacology

UCLA Center for Cannabis and Cannabinoids

Key Achievements

Leading human clinical trials on cannabis for pain, opioid reduction, and understanding sex differences in cannabis effects.

Publications

100+ publications on cannabis pharmacology

Major Contributions

  • •Research on cannabis for chronic pain management
  • •Studies on cannabis as opioid-sparing therapy
  • •Pioneered research on sex differences in cannabis effects
  • •Clinical trials on vaporized cannabis vs oral formulations
  • •Advocated for evidence-based cannabis policy
Dr. Orrin Devinsky
Neurologist & Epilepsy Specialist
CBD for Epilepsy

NYU Langone Comprehensive Epilepsy Center

Key Achievements

Led pivotal clinical trials that resulted in FDA approval of Epidiolex (CBD) for Dravet and Lennox-Gastaut syndromes.

Publications

Principal investigator on Epidiolex trials

Major Contributions

  • •Led clinical trials resulting in first FDA-approved CBD drug
  • •Demonstrated CBD efficacy for treatment-resistant epilepsy
  • •Published landmark studies in NEJM on CBD for seizures
  • •Treated thousands of epilepsy patients with cannabis
  • •Advocated for expanded cannabis epilepsy research
Dr. Margaret Gedde
Pathologist & Cannabis Clinician
Clinical Cannabis Medicine

Gedde Whole Health

Key Achievements

Published groundbreaking case series on cannabis for pediatric epilepsy and developed clinical protocols for diverse conditions.

Publications

Co-author of landmark pediatric epilepsy studies

Major Contributions

  • •Published first case series on cannabis for pediatric epilepsy
  • •Developed clinical protocols for autism, cancer, and pain
  • •Treated thousands of patients with cannabis therapy
  • •Educated physicians through conferences and publications
  • •Advocated for patient access to whole-plant medicine
Steve DeAngelo
Cannabis Activist & Entrepreneur
Industry Advocacy & Social Justice

Harborside Dispensary & Last Prisoner Project

Key Achievements

Founded one of the first legal dispensaries and advocates for cannabis social justice and expungement of cannabis convictions.

Major Contributions

  • •Founded Harborside, one of the first legal dispensaries (2006)
  • •Advocated for medical cannabis patient rights for 40+ years
  • •Co-founded Last Prisoner Project for cannabis justice
  • •Promoted cannabis testing and quality standards
  • •Featured in "Weed Wars" documentary series
Dr. Julie Holland
Psychiatrist & Psychopharmacologist
Cannabis & Mental Health

Author & Medical Advisor

Key Achievements

Author of "The Pot Book" and leading voice on cannabis for mental health, women's health, and psychedelic therapy.

Publications

Author of "The Pot Book" and "Moody Bitches"

Major Contributions

  • •Authored comprehensive medical cannabis reference books
  • •Research on cannabis for anxiety and mood disorders
  • •Advocated for women's access to cannabis medicine
  • •Educated public on cannabis mental health benefits/risks
  • •Pioneered integration of cannabis and psychotherapy
Dr. Staci Gruber
Director of Cognitive & Clinical Neuroimaging
Cannabis Neuroscience

Harvard Medical School / McLean Hospital

Key Achievements

Leading neuroimaging research on how cannabis affects brain function, cognition, and quality of life in medical patients.

Publications

150+ publications on cannabis and the brain

Major Contributions

  • •Neuroimaging studies on cannabis effects on brain function
  • •Research on medical cannabis improving quality of life
  • •Studies on cognitive effects in medical vs recreational users
  • •Pioneered longitudinal cannabis brain research
  • •Educated public on cannabis neuroscience
Dr. Ethan Russo
Neurologist & Psychopharmacology Researcher
Clinical Endocannabinoid Deficiency

International Cannabis and Cannabinoids Institute

Key Achievements

Developed Clinical Endocannabinoid Deficiency theory and pioneered terpene/cannabinoid entourage effect research.

Publications

50+ peer-reviewed papers on cannabis medicine

Major Contributions

  • •Proposed Clinical Endocannabinoid Deficiency (CECD) theory
  • •Extensive research on terpenes and the entourage effect
  • •Developed Sativex (nabiximols) for MS spasticity
  • •Authored definitive reviews on cannabis pharmacology
  • •Advocated for whole-plant medicine over isolates

Note: This list represents a selection of influential figures in cannabis medicine and research. Many other scientists, clinicians, patients, and advocates have contributed significantly to the field. This is not an exhaustive or ranked list.